Original Articles Open Access
Copyright ©The Author(s) 1998. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Feb 15, 1998; 4(1): 28-29
Published online Feb 15, 1998. doi: 10.3748/wjg.v4.i1.28
Aflatoxin sufferer and p53 gene mutation in hepatocellular carcinoma
Zhuo-Lin Deng, Yun Ma, Guangxi Medical University, Nanning 530021, Guangxi Province, China
Zhuo-Lin Deng, male, born on 1929-04-19 in Guangdong Province, Professor of pathology, having 80 papers published.
Author contributions: All authors contributed equally to the work.
Correspondence to: Dr. Zhuo-Lin Deng, Guangxi Medical University, 6 Taoyuanlu, Nanning 530021, Guangxi Province, China
Telephone: +86-771-5311477-8262
Received: September 1, 1997
Revised: October 13, 1997
Accepted: November 3, 1997
Published online: February 15, 1998

Abstract

AIM: To study the p53 gene mutation and its relationship to aflatoxin B1 exposure in hepatocellular carcinoma (HCC).

METHODS: Restriction fragment length polymorphism analysis method was used in 62 HCC samples, and DNA direct sequencing in another 45 HCC samples.

RESULTS: In HCC and AFB1 high and low-risk areas, 36/52 (69%) and 2/10 (20%) cases were found losing the HaeIII allele respectively, suggesting one of the base G mutation at the p53 gene codon 249. Similar results appeared in DNA direct sequencing, 20/35 (57%) and 1/10 (10%) respectively mutated at the codon 249 third base G to C transversion.

CONCLUSION: In HCC after AFB1 exposure, mutation of p53 gene is fixed at codon 249 third base and take the form of G to T transversion. This is a definite marker of mutation which is induced by AFB1 mutagen. It is applicable for molecular epidemiologic survey of the sufferers of AFB1 among HCC cases and for discovering more unknown natural AFB1 contaminated areas.

Key Words: Aflatoxin B1, genes, p53, mutation, carcinoma, hepatocellular, liver neoplasms



INTRODUCTION

Previous reports from Qidong and southern Africa discovered that the p53 gene of hepatocellular carcinoma ( HCC ) had a mutational hot-spot at codon 249[1-3]. Later there were repeated reports from Qidong. However, reports from worldwide other than those two areas showed no such special mutational hot-spot in HCC[4-6]. It was supposed that codon 249 mutation might be caused by exposure to aflatoxin B1 ( AFB1 ) which was a common enviromental factor prevalent in the two mentioned areas. Aspergillus flavus is widely distributed throughout the world. However, well-known natural high AFB1 contaminated areas are uncommon. It is of significance to study one more known natural high AFB1 risk area Fusui and its neighboring counties where HCC mortality rate was high up to 40/100000 annually. AFB1 exposure and hepatitis B virus (HBV) were both suspected to be the principal aetiological factors.

MATERIALS AND METHODS

Surgical specimens of HCC were fixed in formalin and embedded in paraffin. The pathological diagnosis was made by standard histologic criteria. The DNA of 62 HCC samples were amplified focus on the p53 gene exon 7 by polymerase chain reaction (PCR). Primers were introduced by Murakami et al PCR products containing exon 7 were digested with the restriction enzyme Hae III, then eletrophoresed for restriction fragment length polymorphism (RFLP) analysis. Another 45 HCC samples were sent for DNA direct sequencing. In the meantime, all samples were stained for HBsAg by ABC method of immunohistochemistry.

RESULTS

A lot of HCC samples came from high HCC prevalent and high AFB1 exposed area in Guangxi lost the Hae III restriction site GG/CC by method of RFLP analysis. It suggested a mutation occuring at the sequence AGG, CCC. Undoubtedly, the mutational point occurred at the hot-spot codon 249 nucleotides G rather than non-hot-spot C of codon 250. Surprisingly, this mutation was found in 36/52 samples (69%). Compared to the samples from a low prevalent area in Guangxi, the frequency was 2/10 (20%). The difference was significant (P < 0.01). The results by direct DNA sequencing were similar. The samples from high prevalent area were 20/35 (57%) mutation at codon 249 third nucleotide G to T transversion, while low prevalent area showed this transversion only in 1/10 (10%). The difference was also significant (P < 0.01). The total positive rate of HBsAg was 94.4%, with no difference between high and low prevalent areas.

DISCUSSION

The p53 tumor suppressor gene is one of the genes with great interest, because it is commonly mutated in human cancer, and the spectra of p53 mutations in these cancers provide clues to the etiology and molecular pathogenesis of tumors. In HCC, p53 gene mutation is related to AFB1 and HBx protein of HBV. The present data is a research on the spot on great number of cases. The conclusions are as follows: the principal etiology and molecular pathogenesis of HCC at the part of high prevalent area in Guangxi are caused by AFB1 without doubt, and HBV chronic infection is also high. AFB1 induces p53 gene mutational hot-spot in the high prevalent local area up to 57%-69%. This hot-spot is located at exon 7 codon 249 third nucleotide G to T transversion. It is a special and stable mutational point. It is useful for HCC molecular epidemiologic study for general survey whether the residents are at the risk of aflatoxin exposure, and distinguish the AFB1 sufferers of HCC cases individually. Until now, there has been no report from high AFB1 contaminated area where HCC samples escape this p53 gene mutational hot-spot. More and more human materials from high AFB1 areas show the mutation point clustering at the codon 249 third nucleotide rather than the first or second nucleotide, and only G to T single form but not G to A or C multiple forms mutation. Therefore it would be confirmed as a mutational marker of a AFB1 sufferer in human HCC.

Footnotes

Project supported by the National Natural Science Foundation of China, No. 39560030. and Natural Science Foundation of Guangxi

References
1.  Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature. 1991;350:427-428.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1066]  [Cited by in F6Publishing: 1109]  [Article Influence: 33.6]  [Reference Citation Analysis (0)]
2.  Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature. 1991;350:429-431.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 972]  [Cited by in F6Publishing: 1001]  [Article Influence: 30.3]  [Reference Citation Analysis (0)]
3.  Ozturk M. p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet. 1991;338:1356-1359.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 299]  [Cited by in F6Publishing: 264]  [Article Influence: 8.0]  [Reference Citation Analysis (0)]
4.  Li D, Cao Y, He L, Wang NJ, Gu JR. Aberrations of p53 gene in human hepatocellular carcinoma from China. Carcinogenesis. 1993;14:169-173.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 82]  [Cited by in F6Publishing: 67]  [Article Influence: 2.2]  [Reference Citation Analysis (0)]
5.  Fujimoto Y, Hampton LL, Wirth PJ, Wang NJ, Xie JP, Thorgeirsson SS. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China. Cancer Res. 1994;54:281-285.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  Scorsone KA, Zhou YZ, Butel JS, Slagle BL. p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China. Cancer Res. 1992;52:1635-1638.  [PubMed]  [DOI]  [Cited in This Article: ]
7.  Yet FS, Yu MC, Mo CC. Hepatitis B virus, aflatoxin, and hepatocellular carci noma in southern Guangxi, China. Cancer Res. 1989;49:2506-2509.  [PubMed]  [DOI]  [Cited in This Article: ]
8.  Murakami Y, Hayashi K, Hirohashi S, Sekiya T. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res. 1991;51:5520-5525.  [PubMed]  [DOI]  [Cited in This Article: ]